Assets in USD of Aspire Biopharma Holdings, Inc. from Q4 2021 to Q3 2025

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Aspire Biopharma Holdings, Inc. quarterly Assets history and growth rate from Q4 2021 to Q3 2025.
Aspire Biopharma Holdings, Inc. Assets for the quarter ending September 30, 2025 was $2.4M, a 63.9% decline year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Aspire Biopharma Holdings, Inc. Quarterly Assets (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2025	$2.4M	-$4.26M	-63.9%	Sep 30, 2025	10-Q/A	2025-11-14
Q2 2025	$989K	-$5.88M	-85.6%	Jun 30, 2025	10-Q	2025-08-13
Q1 2025	$1.97M	-$18.2M	-90.3%	Mar 31, 2025	10-Q/A	2025-08-13
Q4 2024	$148K	-$19.8M	-99.3%	Dec 31, 2024	10-Q/A	2025-11-14
Q3 2024	$6.66M	-$13.2M	-66.5%	Sep 30, 2024	10-Q	2024-11-14
Q2 2024	$6.87M	-$13.7M	-66.6%	Jun 30, 2024	10-Q	2024-08-16
Q1 2024	$20.2M	-$283M	-93.3%	Mar 31, 2024	10-Q	2024-06-05
Q4 2023	$20M	-$280M	-93.3%	Dec 31, 2023	10-K	2025-04-07
Q3 2023	$19.9M	-$278M	-93.3%	Sep 30, 2023	10-Q	2023-11-08
Q2 2023	$20.6M	-$276M	-93.1%	Jun 30, 2023	10-Q	2023-08-08
Q1 2023	$303M	+$6.61M	+2.23%	Mar 31, 2023	10-Q	2023-05-11
Q4 2022	$300M	+$300M	+102274%	Dec 31, 2022	10-K	2024-03-11
Q3 2022	$298M			Sep 30, 2022	10-Q	2022-11-10
Q2 2022	$297M			Jun 30, 2022	10-Q	2022-08-11
Q1 2022	$297M			Mar 31, 2022	10-Q	2022-05-16
Q4 2021	$293K			Dec 31, 2021	10-K	2023-03-21

* An asterisk sign (*) next to the value indicates that the value is likely invalid.